Gil M. Labrucherie, SVP, COO & CFO at NEKTAR THERAPEUTICS (NKTR), sold 15,796 shares at $18.30 ($289K) on 2021-05-17, disclosed to the SEC on 2021-05-19.
Seasonal sale ($289k) by SVP, COO & CFO — this insider has traded NKTR in May in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.30 | 7,898 | $145K | 50.0% |
| 2 | $18.30 | 7,898 | $145K | 50.0% |
| Total | $18.30 avg | 15,796 | $289K | 100% |
| Filing → |
| NKTR | SELL | 2022-05-17 | $138K | — | Filing → |
| RZLT | BUY | 2022-05-09 | $400K | — | Filing → |
| NKTR | SELL | 2022-02-18 | $166K | — | Filing → |